Search

Codexis Inc

Geschlossen

BrancheGesundheitswesen

0.98 -1.01

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

0.94

Max

1.01

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.3M

-12M

Verkäufe

-333K

15M

EPS

-0.13

Gewinnspanne

-80.489

Angestellte

146

EBITDA

-3.4M

-9.8M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+550% upside

Dividenden

By Acuity

Nächstes Ergebnis

12. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-40M

122M

Vorheriger Eröffnungskurs

1.99

Vorheriger Schlusskurs

0.98

Codexis Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Nov. 2026, 21:06 UTC

Codexis, Inc. shares fell significantly lower, finishing near the low end of their recent trading range and below the 20-day moving average.

10. Nov. 2026, 21:01 UTC

News

Codexis, Inc. announced a $60 million loan agreement with Trinity Capital to refinance debt and advance its ECO Synthesis Manufacturing Platform for siRNA therapeutics.

9. Nov. 2026, 21:07 UTC

News

Codexis highlights advancements in its ECO Synthesis platform at TIDES Europe 2026, achieving over 90% product quality and reducing cycle time significantly.

6. Nov. 2026, 21:05 UTC

Macro Event

Codexis, Inc. shares are advancing sharply, supported by a rise in the Michigan Consumer Sentiment Index to 51.0, exceeding expectations.

5. Nov. 2026, 20:46 UTC

Codexis, Inc. shares fell sharply, retracing significantly since Wednesday's close and remaining near the lower end of their one-month range.

4. Nov. 2026, 21:07 UTC

Codexis, Inc. is trading roughly flat, maintaining a position near unchanged since Tuesday's close, despite earlier reaching a high of 3.70%.

3. Nov. 2026, 20:51 UTC

Codexis, Inc. is trading higher, recovering from a low point yesterday and maintaining a positive return since Monday's close.

2. Nov. 2026, 21:05 UTC

Codexis, Inc. shares fell sharply, reversing an initial gain to reach a session low, continuing a broader downward trend over the past month.

29. Okt. 2026, 20:02 UTC

News

Codexis, Inc. will report its third-quarter 2026 financial results on November 12, 2026, after market close, with a conference call at 4:30 PM ET.

28. Okt. 2026, 20:01 UTC

Codexis, Inc. shares are rising during Wednesday's trading session, gaining ground since Tuesday's close.

27. Okt. 2026, 20:07 UTC

Codexis, Inc. shares are declining, moving lower from Monday's close and significantly below their 20-day moving average.

23. Okt. 2026, 19:26 UTC

Codexis Inc shares fell significantly, remaining well below their 20-day moving average amid a challenging backdrop for the life sciences sector.

22. Okt. 2026, 20:07 UTC

Codexis Inc shares are advancing, having peaked earlier in the day, though currently positioned below its 20-day moving average within its one-month trading range.

21. Okt. 2026, 20:07 UTC

Codexis Inc shares are advancing.

20. Okt. 2026, 20:01 UTC

Codexis Inc shares fell sharply, trading well below their 20-day moving average and near the lower end of their one-month trading range.

19. Okt. 2026, 20:01 UTC

Codexis Inc shares are trading sharply higher, reflecting strong performance as the stock remains in the middle of its one-month trading range.

16. Okt. 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a decline since Thursday's close and trading significantly below its 20-day moving average.

15. Okt. 2026, 20:02 UTC

Codexis Inc shares are advancing, recovering from an early dip to finish notably higher, though still below the 20-day moving average.

14. Okt. 2026, 23:06 UTC

Codexis Inc is advancing in after-market trading, gaining ground since Wednesday's close, though it remains below its 20-day moving average.

13. Okt. 2026, 20:01 UTC

Codexis Inc shares fell sharply, breaking a streak of higher daily closes since Monday, diverging from recent upward momentum.

8. Okt. 2026, 19:24 UTC

Codexis Inc shares fell sharply, continuing a downward trend from Wednesday's close, reaching their lowest point shortly after the market opened.

7. Okt. 2026, 20:00 UTC

Codexis Inc is advancing in Wednesday's trading session, having previously peaked over 5% while remaining above its 20-day moving average.

5. Okt. 2026, 20:06 UTC

Codexis Inc is trading modestly higher, fluctuating around the midpoint of its one-month range after peaking in the early afternoon.

1. Okt. 2026, 20:01 UTC

Codexis Inc shares fell amid declines in the Life Sciences Tools & Services sub-sector, remaining below the 20-day moving average.

30. Sept. 2026, 20:01 UTC

Codexis Inc is advancing in Wednesday's market session, having peaked earlier before pulling back, but remains below its 20-day moving average.

25. Sept. 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a trend of lower performance amid broader market volatility and declines over the past three sessions.

24. Sept. 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a decline since Wednesday and closing below its 20-day moving average near the lower end of its one-month range.

23. Sept. 2026, 20:07 UTC

Codexis Inc shares fell as concerns about inflation and rising bond yields weighed on investor sentiment, pulling back after an earlier session rebound.

22. Sept. 2026, 20:01 UTC

Codexis Inc shares are up significantly in the current session, marking the third consecutive day of gains, despite remaining below the 20-day moving average.

18. Sept. 2026, 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

Peer-Vergleich

Kursveränderung

Codexis Inc Prognose

Kursziel

By TipRanks

550% Vorteil

12-Monats-Prognose

Durchschnitt 6.5 USD  550%

Hoch 8 USD

Tief 5 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Codexis Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
help-icon Live chat